Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Erasca, Inc. | 120,000 | reported | 24 Jun 2025 | tx 5+286,000 |
| FIVE PRIME THERAPEUTICS INC | 95,919 | reported | 11 Nov 2015 | tx 16+231,744−45,108 |
| IDEAYA Biosciences, Inc. | 62,500 | reported | 21 Feb 2020 | tx 1+62,500 |
| SpringWorks Therapeutics, Inc. | 0 | reported | 01 Jul 2025 | tx 24+101,475−94,477 |
| IGM Biosciences, Inc. | 0 | reported | 14 Aug 2025 | tx 13+123,052−35,264 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Aug 2025 | OTHER | IGM Biosciences, Inc. | 2,000 | — | |
| 01 Jul 2025 | OTHER | SpringWorks Therapeutics, Inc. | 14,155 | — | |
| 01 Jul 2025 | OTHER | SpringWorks Therapeutics, Inc. | 14,668 | — | deriv |
| 01 Jul 2025 | OTHER | SpringWorks Therapeutics, Inc. | 12,216 | — | deriv |
| 01 Jul 2025 | OTHER | SpringWorks Therapeutics, Inc. | 15,318 | — | deriv |
| 24 Jun 2025 | GRANT_AWARD | Erasca, Inc. | 120,000 | 0.00 USD | deriv |
| 14 May 2025 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 10,060 | 0.00 USD | |
| 10 Feb 2025 | SALE | SpringWorks Therapeutics, Inc. | 13,774 | 53.01 USD | |
| 10 Feb 2025 | EXERCISE | SpringWorks Therapeutics, Inc. | 13,774 | 32.27 USD | |
| 10 Feb 2025 | EXERCISE | SpringWorks Therapeutics, Inc. | 13,774 | 0.00 USD | deriv |
| 25 Jul 2024 | SALE | IGM Biosciences, Inc. | 15,132 | 14.00 USD | |
| 25 Jul 2024 | EXERCISE | IGM Biosciences, Inc. | 15,132 | 1.39 USD | |
| 25 Jul 2024 | EXERCISE | IGM Biosciences, Inc. | 15,132 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Erasca, Inc. | 60,000 | 0.00 USD | deriv |
| 03 Jun 2024 | SALE | SpringWorks Therapeutics, Inc. | 931 | 41.49 USD | |
| 03 Jun 2024 | SALE | SpringWorks Therapeutics, Inc. | 20 | 42.09 USD | anomaly |
| 03 Jun 2024 | SALE | SpringWorks Therapeutics, Inc. | 751 | 40.57 USD | |
| 03 Jun 2024 | SALE | SpringWorks Therapeutics, Inc. | 2,946 | 39.41 USD | |
| 16 May 2024 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 4,095 | 0.00 USD | |
| 16 May 2024 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 12,216 | 0.00 USD | deriv |
| 12 Mar 2024 | GRANT_AWARD | IGM Biosciences, Inc. | 29,400 | 0.00 USD | deriv |
| 19 Jul 2023 | SALE | SpringWorks Therapeutics, Inc. | 2,418 | 29.31 USD | |
| 22 Jun 2023 | GRANT_AWARD | Erasca, Inc. | 60,000 | 0.00 USD | deriv |
| 20 Jun 2023 | SALE | SpringWorks Therapeutics, Inc. | 2,400 | 26.92 USD | |
| 24 May 2023 | GRANT_AWARD | SpringWorks Therapeutics, Inc. | 4,648 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 20 Jul 2021.